SGHT CIK: 1531177

Sight Sciences, Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
277
FY22:
210
FY23:
163
FY24:
140
FY25:
113
(positive)
Change from FY21 to FY25
millions USD
FY21:
3.15
FY22:
3.40
FY23:
3.78
FY24:
3.07
FY25:
2.57
Total assets
Change from FY21 to FY25
millions USD
FY21:
280
FY22:
213
FY23:
167
FY24:
143
FY25:
115

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
13.5
FY22:
17.8
FY23:
12.3
FY24:
15.5
FY25:
11.0
(negative)
Change from FY21 to FY25
millions USD
FY21:
34.6
FY22:
35.2
FY23:
34.2
FY24:
39.8
FY25:
40.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
232
FY22:
160
FY23:
120
FY24:
87.5
FY25:
63.9
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
280
FY22:
213
FY23:
167
FY24:
143
FY25:
115

All amounts in millions USD Data source:SEC EDGAR